CLINICAL_TRIALS
trial_result
· 2014-06-06
Clinical Trial Update: DIabetic Retinopathy Candesartan Trials [Phase 3]
Summary
Phase 3 trials evaluating candesartan for diabetic retinopathy in patients with type 2 diabetes have completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2014-06-06